For example, triple negative breast cancer (TNBC) has a higher level of programmed cell death ligand 1 (PD-L1) expression, which is more likely to benefit from immune checkpoint treatment than other breast cancer subtypes. The gene discussed is CD274; the disease is breast carcinoma.